Filament Health Corp. (FH.NE)

CAD 0.04

(0.0%)

Market Cap (In CAD)

9.16 Million

Revenue (In CAD)

2.13 Million

Net Income (In CAD)

-5.32 Million

Avg. Volume

58.85 Thousand

Currency
CAD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.025-0.18
PE
-
EPS
-
Beta Value
1.0
ISIN
CA31685W1068
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Benjamin Lightburn
Employee Count
-
Website
https://filament.health
Ipo Date
2021-06-24
Details
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.